Abstinência aguda de álcool e delirium tremens
Revisado por Dr Toni Hazell, MRCGPÚltima atualização por Dr Philippa Vincent, MRCGPÚltima atualização 18 Fev 2026
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Versão em Áudio
Profissionais de Saúde
Os artigos de Referência Profissional são projetados para uso por profissionais de saúde. Eles são escritos por médicos do Reino Unido e baseados em evidências de pesquisa, diretrizes do Reino Unido e da Europa. Você pode encontrar o Abstinência de álcool e desintoxicação alcoólica artigo mais útil, ou um dos nossos outros artigos de saúde.
Neste artigo:
This article focuses specifically on acute alcohol withdrawal and delirium tremens. The National Institute for Health and Care Excellence (NICE) has developed guidelines for the clinical management of alcohol use disorders and this article is based on these.123
See related separate articles Alcoolismo e uso indevido de álcool - reconhecimento e avaliação, Alcoholism and alcohol dependence - management e Alcohol-related problems.
Continue lendo abaixo
Epidemiologia4
In England in 2022, 56% of adults report drinking alcohol weekly (61% of men and 51% of women). 32% of men exceed the recommended weekly amount compared with 15% of women. The mean number of units consumed by all adults in England per week was 13.35About 20% of people in the UK report drinking no alcohol.5
Alcohol use changed during the COVID pandemic with heavy drinkers tending to drink more and lighter drinkers tending to drink less.26
Alcohol drinking at hazardous, harmful or dependent levels can be characterised as Alcohol Use Disorder (AUD).
18% of adults in England drink at hazardous levels (AUDIT score of 8+) with 1.8% drinking harmful levels and 0.9% affected by alcohol dependence.
Men are more likely to drink at hazardous levels or above than women.
Drinking at hazardous levels or above has fallen from 26% in 2000 to 18% in 2024.
Drinking at hazardous levels fell the most amongst people aged 16-24 (40% to 18%), and also reduced in 24-44 year olds. The numbers drinking at hazardous levels was stable in people between 45 and 74 and increased in those aged over 75 (6% to 10%)
Having a common mental health condition (depression or anxiety)7 is related to increased risks of hazardous drinking. 3% of adults with a common mental health condition drink at harmful levels and 2.3% have probable alcohol dependence, compared with 1.4% and 0.6% of the general population.
Higher alcohol intake is found in the most deprived groups; it also varies by region (highest in Northern England) and by ethnicity (highest amongst white British people).
Data is unclear about the prevalence of alcohol withdrawal symptoms and delirium tremens. Most studies suggest that up to 1.8% of people with alcohol use disorder develop delirium tremens upon stopping drinking although others suggest up to 12 % can be affected.8
Up to 50% of people with AUD experience some withdrawal symptoms upon decreasing or stopping.9
Acute alcohol withdrawal
Voltar ao conteúdoAcute alcohol withdrawal can be a complex issue. Some patients have no significant symptoms; others have mild alcohol withdrawal symptoms and can be managed in the community depending on their clinical assessment at that time; still others have more severe symptoms or a history of adverse outcomes, and need close inpatient supervision.10
It is important to recognise that, in the UK, if alcohol withdrawal needs clinical oversight in the community then this should be provided by alcohol and drug services. General practice can offer advice about not reducing alcohol abruptly or too quickly whilst waiting for specialist support and can prescribe prophylactic oral thiamine.2
More specialist drugs to manage the symptoms of withdrawal should not be prescribed in general practice.
Problems associated with alcohol withdrawal can include:
Uncomfortable withdrawal symptoms, such as anxiety, tremors, headache, nausea/vomiting, diaphoresis, or palpitations .
Delirium tremens.
Convulsões.
Depressão.
Polysubstance abuse.
Electrolyte disturbances.
Complications due to associated liver disease.
Apresentação
This may be in a number of different ways:
A patient may present in acute alcohol withdrawal.
A patient may be admitted to hospital for another reason and thus an unplanned alcohol withdrawal may be precipitated. Alcohol-use disorders can complicate the assessment and treatment of other medical and psychiatric problems.
A patient may present wishing to abstain from alcohol but be seen as at risk of acute alcohol withdrawal.
Alcohol withdrawal symptoms
Symptoms typically present about eight hours after a significant fall in blood alcohol levels. They peak at about 72 hours and, by day 4 or 5, the symptoms have usually improved significantly.11
Minor withdrawal symptoms (can appear 6-12 hours after alcohol has stopped):
Insomnia and fatigue.
Tremor.
Mild anxiety/feeling nervous.
Mild restlessness/agitation.
Náusea e vômito.
Dor de cabeça.
Suor excessivo.
Anorexia.
Craving for alcohol.
Alcoholic hallucinosis occurs in about 2% of cases of acute alcohol withdrawal (can appear 12-24 hours after alcohol has stopped):11
Includes visual, auditory or tactile hallucinations.
Withdrawal seizures occur in up to a third of cases of acute alcohol withdrawal (can appear 24-48 hours after alcohol has stopped):
These are generalised tonic-clonic seizures.
Alcohol withdrawal delirium or 'delirium tremens' (can appear 48-72 hours after alcohol has stopped).
NOTE that alcohol withdrawal shows a "kindling" or sensitisation phenomenon, whereby subsequent withdrawal attempts tend to result in increased severity of symptoms, particularly around seizure activities. Repeated alcohol withdrawals lower the seizure threshold and increase the likelihood of seizures.11
História
Ask about:
Quantity of alcoholic intake and duration of alcohol use.
Time since last drink.
Whether previous alcohol withdrawals have been attempted.
Medical history including psychiatric history.
Medication history (including prescribed drugs and drugs of misuse and any drug allergies).
Support network.
Note that many patients may not actually be trying to stop drinking. They may either have an intercurrent illness stopping them from drinking or problems with alcohol availability.
Treatment of alcohol withdrawal symptoms
The aim of medically assisted withdrawal is to prevent complications including seizures and delirium tremens, as well as making withdrawal more comfortable for the patient and providing an environment where interventions that can help maintain abstinence may be introduced.
Decide on whether the patient needs to be admitted to hospital
Previous delirium tremens or alcohol withdrawal seizures or presence of autonomic overactivity or age <18 years are all associated with a higher risk of developing acute alcohol withdrawal and these patients should be admitted. Also, consider admission if there are concerns about the patient's safety - eg, living alone or with psychiatric problems. Patients who have failed detoxification at home should also be admitted and it should be considered in those who have other substance misuse.
Patients with suspected Wernicke's encephalopathy need urgent admission for treatment with intravenous thiamine.
Is medication always needed for detoxification?
Medication may not be needed for detoxification if:
A male patient is drinking <15 units/day or a female patient is drinking <10 units/day AND they do not report any recent withdrawal symptoms or recent drinking to prevent withdrawal symptoms.
The patient has no withdrawal signs or symptoms.
A scale has also been suggested to assess the severity of the alcohol withdrawal syndrome: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar).11
Medications for acute alcohol withdrawal
Benzodiazepines
Benzodiazepines are the recommended drugs for detoxification. They have a slower onset of action and therefore are less likely to lead to misuse. A reducing dose of chlordiazepoxide over 5-7 days is commonly used. Diazepam is an alternative.
Ideally, the patient should be seen daily by their alcohol team and the medication should be dispensed daily.
The benzodiazepine should be stopped once detoxification is complete or if the patient relapses and starts drinking again during detoxification.
A British Medical Journal (BMJ) review has suggested the following regimen for moderate alcohol dependence being treated under an alcohol team or as an inpatient (this should not be prescribed by general practice, unless under an agreed and funded shared care arrangement with an alcohol team):
Day 1: 20 mg chlordiazepoxide four times daily.
Day 2: 15 mg chlordiazepoxide four times daily.
Day 3: 10 mg chlordiazepoxide four times daily.
Day 4: 5 mg chlordiazepoxide four times daily.
Day 5: 5 mg chlordiazepoxide twice daily.
Dose depends on factors including level of alcohol dependence, sex, weight and current liver function. Smaller doses may be needed for mild dependence and larger doses for severe dependence. People at high risk of seizures or delirium tremens may need a longer period of treatment (maximum of two weeks).
For mild/moderate alcohol detoxification in secondary care, some hospitals have a system whereby regular reducing doses of chlordiazepoxide are not given due to concerns about sedative effects. They have a point score where nurses regularly make an assessment and, depending on the patient's score, they are given a certain dose of benzodiazepine (usually diazepam).
Thiamine12
Thiamine deficiency is common in people who are alcohol-dependent, due to their poor diet, the presence of gastritis which can affect its absorption, and also the fact that it is a coenzyme in alcohol metabolism.
Deficiency can cause Wernicke's encephalopathy, which if left untreated, can lead to Korsakoff's syndrome.
Oral thiamine is poorly absorbed in dependent drinkers. For this reason, all those undergoing detoxification in the community should be considered for admission for parenteral high-potency B complex vitamins (Pabrinex®) as prophylactic treatment. However, because of the risk of anaphylaxis, resuscitation facilities need to be available at the time of administration. The risk of anaphylaxis is lower if the drug is given intramuscularly (IM).
As prophylactic treatment, 250 mg of thiamine should be given IM or intravenously (IV) once a day for three to five days.
If the patient is healthy and well nourished and alcohol dependence is uncomplicated then an alternative is oral thiamine at a minimum dose of 300 mg per day during detoxification (given as divided doses).
Ongoing prescription of lower doses of thiamine is suggested if there is concern about chronic deficiency after this. NICE Clinical Knowledge Summaries (NICE CKS) recommends that 50 mg daily be taken.
Informações importantes |
|---|
Other drugs Clomethiazole may be better than benzodiazepines in preventing alcoholic delirium but it is more likely to lead to dependence and there is also a problem with toxicity if there is significant hepatic impairment. It is suggested that it be reserved for second-line use in an inpatient setting. A 2020 randomised controlled trial evaluated the response of 145 community patients to gabapentin vs placebo assessed by the number of no drinking or fewer heavy drinking days observed.13 Gabapentin performed well in this setting and was significantly more efficacious than placebo. Carbamazepine isn't recommended for routine use but it may be useful if there is a history of withdrawal seizures. Antipsychotic drugs should not be routinely used. |
Patients may also need to be referred to other specialities - eg, hepatologists, psychiatrists.
Continue lendo abaixo
Delirium tremens (DT)
Voltar ao conteúdoThis is a medical emergency. A hyperadrenergic state is present. The prevalence of DT in the general population is <1% and nearly 2% in patients with alcohol dependence.14
Características clínicas
Delirium tremens usually begins 24-72 hours after alcohol consumption has been reduced or stopped .
The symptoms/signs differ from usual withdrawal symptoms in that there are signs of altered mental status. These can include:
Hallucinations (auditory, visual, or olfactory).
Confusão.
Delusions.
Severe agitation.
Seizures can also occur.
Examination may reveal signs of chronic alcohol abuse/stigmata of chronic liver disease. There may also be:
Taquicardia.
Hyperthermia and excessive sweating.
Hipertensão.
Taquipneia.
Tremor.
Mydriasis.
Ataxia.
Altered mental status.
Cardiovascular collapse.
Fatores de risco
Previous history of delirium tremens.
Previous history of alcohol withdrawal seizures.
Co-existing infection or medical problems including pancreatitis or hepatitis.
Recent higher-than-normal levels of alcohol intake.
Idade avançada.
Abnormal liver function.
More severe withdrawal symptoms on presentation.
Investigações
This is a clinical diagnosis and there is often a known history of alcohol misuse/dependence.
Blood tests can help to assess other medical problems. Dehydration and electrolyte disturbance may be present. Tests can include:
Hemograma completo.
Testes de função hepática.
Clotting.
Arterial blood gases (to look for metabolic acidosis).
Glicose.
Blood alcohol levels.
U&Es e creatinina.
Amylase.
Creatine phosphokinase (especially if the patient was unconscious for a long time, due to risk of rhabdomyolysis).
Blood cultures (if there are concerns about infection).
CXR should be considered if there are signs of respiratory distress. Co-existing pneumonia is common. There is also the possibility of aspiration, especially if reduced consciousness or seizures have occurred.
CT scan of the head may be needed if there are seizures or there is evidence of a recent head injury.
ECG may show an arrhythmia.
Gestão
This should be in a hospital setting. Intensive care may be needed for very unwell patients.
It should first include assessment and management of 'Airway, Breathing and Circulation (ABC)' .
Any hypoglycaemia should be treated.
Sedation with benzodiazepines is suggested. Diazepam or lorazepam are preferred depending on treatment regime.
In benzodiazepine refractory cases, phenobarbital, propofol, and dexmedetomidine could be used.14 15
Patients with delirium tremens may also have Wernicke's encephalopathy and should be treated for both conditions:
At least two pairs of ampoules of Pabrinex® (500 mg thiamine) should be given IV three times daily for three days.
If the patient does not respond, treatment should be discontinued.
If signs or symptoms respond to treatment, continue with two ampoules of Pabrinex® once daily for five days or for as long as improvement continues.
Prognóstico
The mortality rate with early recognition and treatment is less than 5%.16
Follow-up after detoxification and acute alcohol withdrawal
Voltar ao conteúdoClose follow-up is needed.
Counselling, self-help and groups including Alcoholics Anonymous may be helpful.
Drugs can be used in abstinence to help prevention of relapse. These are discussed in the separate Alcoholism and alcohol dependence - management article. Again these should be prescribed by alcohol services who have the skills and expertise to manage them.
Any co-existing medical and psychological problems should also be addressed.
Continue lendo abaixo
Prevention of acute alcohol withdrawal and delirium tremens
Voltar ao conteúdoIf problem drinking is identified early, it may mean that complications, including severe alcohol withdrawal and delirium tremens, are avoided.
Patients admitted to hospital should always be screened for alcohol dependence.
There is some evidence that a ketogenic diet reduces withdrawal symptoms.17
Leitura adicional e referências
- Sullivan JT, Sykora K, Schneiderman J, et al; Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989 Nov;84(11):1353-7.
- Alcoholics Annonymous
- Alcohol interventions in secondary and further education; NICE guideline (August 2019)
- BMJ Best Practice; Alcohol withdrawal (Feb 2020)
- Alcohol-use disorders: Diagnosis and clinical management of alcohol-related physical complications; NICE Clinical Guideline (June 2010, last updated April 2017)
- Álcool - consumo problemático; NICE CKS, maio de 20253 (acesso apenas no Reino Unido)
- Transtornos relacionados ao uso de álcool: diagnóstico, avaliação e manejo do consumo nocivo e dependência de álcool; Diretriz Clínica NICE (Fevereiro de 2011 - última atualização em outubro de 2014)
- Statistics on Alcohol: England; House of Commons Library, 2024
- Alcohol Statistics; Mudança de Álcool UK
- Chapter 5: Alcohol: hazardous, harmful and dependent patterns of drinking; Adult Psychiatric Morbidity Survey: Survey of Mental Health and Wellbeing, England, 2023/4
- Associations of common mental disorder with alcohol use in the adult general population: a systematic review and meta‐analysis; J-A Puddephatt et al; Addiction
- Delirium Tremens: Assessment and Management; S Grover et al; Journal of Clinical and Experimental Hepatology
- Managing Alcohol Withdrawal Syndrome; M Gottlieb et al; Annals of Emergency Medicine
- Wood E, Albarqouni L, Tkachuk S, et al; Will This Hospitalized Patient Develop Severe Alcohol Withdrawal Syndrome?: The Rational Clinical Examination Systematic Review. JAMA. 2018 Aug 28;320(8):825-833. doi: 10.1001/jama.2018.10574.
- Canver BR, Newman RK, Gomez AE; Alcohol Withdrawal Syndrome.
- Shakory S; Thiamine in the management of alcohol use disorders. Can Fam Physician. 2020 Mar;66(3):165-166.
- Anton RF, Latham P, Voronin K, et al; Eficácia da Gabapentina para o Tratamento do Transtorno do Uso de Álcool em Pacientes com Sintomas de Abstinência Alcoólica: Um Ensaio Clínico Randomizado. JAMA Intern Med. 1 de maio de 2020;180(5):728-736. doi: 10.1001/jamainternmed.2020.0249.
- Grover S, Ghosh A; Delirium Tremens: Assessment and Management. J Clin Exp Hepatol. 2018 Dec;8(4):460-470. doi: 10.1016/j.jceh.2018.04.012. Epub 2018 May 5.
- Yavarovich ER, Bintvihok M, McCarty JC, et al; Association between dexmedetomidine use for the treatment of alcohol withdrawal syndrome and intensive care unit length of stay. J Intensive Care. 2019 Nov 4;7:49. doi: 10.1186/s40560-019-0405-1. eCollection 2019.
- Rahman A, Paul M; Delirium Tremens
- Wiers CE, Vendruscolo LF, van der Veen JW, et al; Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents. Sci Adv. 2021 Apr 9;7(15). pii: 7/15/eabf6780. doi: 10.1126/sciadv.abf6780. Print 2021 Apr.
Continue lendo abaixo
Histórico do artigo
As informações nesta página são escritas e revisadas por clínicos qualificados.
Next review due: 18 Aug 2030
18 Fev 2026 | Última versão

Pergunte, compartilhe, conecte-se.
Navegue por discussões, faça perguntas e compartilhe experiências em centenas de tópicos de saúde.

Sentindo-se mal?
Avalie seus sintomas online gratuitamente